Skip to content

A CLINICAL STUDY TO EVALUATE THE EFFECT OF A HERBAL DRINK NAGARMOTHADI PANAK (NAGARMOTHA-DADIM-LAJA PANAK) IN REDUCING EXCESSIVE THIRST DURING ALCOHOL WITHDRAWAL

RANDOMIZED OPEN CONTROL CLINICAL TRIAL TO EVALUATE THE EFFICACY OF NAGARMOTHA-DADIM-LAJA PANAK IN MADATYAYA W.S.R. TO TRISHNA IN ALCOHOL WITHDRAWAL SYNDROME - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110481
Enrollment
90
Registered
2026-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

Intervention1: Nagarmotha Dadim Laja Panak: Nagarmotha Dadim Laja Panak will be administered in a dose of 100 ml twice daily before meals for 30 days along with standard treatment. The formulation con

Sponsors

DRRACHANA NARENDRAKUMAR BHANDARI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male patients aged 18 to 60 years diagnosed with Alcohol Withdrawal Syndrome. Patients presenting with Trishna and mild to moderate withdrawal symptoms. Medically stable and fit for oral administration of study drug. Willing to participate and provide written informed consent. Not enrolled in any other clinical trial.

Exclusion criteria

Exclusion criteria: Patients with severe withdrawal symptoms such as seizures or delirium tremens. Patients with liver cirrhosis, chronic kidney disease, severe cardiac disorders, uncontrolled diabetes mellitus or hypertension. Patients with psychiatric disorders. Patients with Sjogrens syndrome, diabetes insipidus or SIADH. Known hypersensitivity to study drug. Patients receiving other therapies for alcohol withdrawal outside study protocol.

Design outcomes

Primary

MeasureTime frame
Reduction in Trishna score assessed using subjective grading scale in patients with Alcohol Withdrawal SyndromeTimepoint: 30 Days

Secondary

MeasureTime frame
Reduction in Daha burning sensation scoreTimepoint: Day 0 Day 7 Day 15 Day 30;Improvement in Murcha faintness and Aruchi anorexiaTimepoint: Day 0 Day 7 Day 15 Day 30;Reduction in Glani fatigue and Chhardi vomitingTimepoint: Day 0 Day 7 Day 15 Day 30;Improvement in hydration related parameters such as fluid intake urination and drynessTimepoint: Day 0 Day 7 Day 15 Day 30;Assessment of safety tolerability and patient complianceTimepoint: Throughout study period up to Day 30

Countries

India

Contacts

Public ContactDR RACHANA NARENDRAKUMAR BHANDARI

Yashwant Ayurvedic Medical College P G Training and Research Centre

drvijay.patilayu@gmail.com7507313566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026